NEW YORK (360Dx) – Recently released changes to how market-based lab pricing data will be collected as part of the Protecting Access to Medicare Act do not go far enough to address concerns of the lab industry, lab groups said.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.